Market Research Logo

Traveler's Diarrhea - Pipeline Review, H2 2015

Traveler's Diarrhea - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Traveler's Diarrhea - Pipeline Review, H2 2015’, provides an overview of the Traveler's Diarrhea’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Traveler's Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Traveler's Diarrhea and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Traveler's Diarrhea
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Traveler's Diarrhea and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Traveler's Diarrhea products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Traveler's Diarrhea pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Traveler's Diarrhea
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Traveler's Diarrhea pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Introduction
Global Markets Direct Report Coverage
Traveler's Diarrhea Overview
Therapeutics Development
Pipeline Products for Traveler's Diarrhea - Overview
Pipeline Products for Traveler's Diarrhea - Comparative Analysis
Traveler's Diarrhea - Therapeutics under Development by Companies
Traveler's Diarrhea - Therapeutics under Investigation by Universities/Institutes
Traveler's Diarrhea - Pipeline Products Glance
Late Stage Products
Clinical Stage Products
Early Stage Products
Traveler's Diarrhea - Products under Development by Companies
Traveler's Diarrhea - Products under Investigation by Universities/Institutes
Traveler's Diarrhea - Companies Involved in Therapeutics Development
Chiesi Farmaceutici SpA
Cosmo Pharmaceuticals S.p.A
GlaxoSmithKline Plc
Nippon Shinyaku Co., Ltd.
Prokarium Limited
Scandinavian Biopharma Holding AB
Sigmoid Pharma Limited
Traveler's Diarrhea - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
ACE-527 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ACE-920 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Etvax - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GVXNSD-133 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Helicobacter pylori [Hel-305] (multivalent) vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
IMSUTMR-1501 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
prulifloxacin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
rifamycin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Typhetec - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Vaccine to Target Capsular Vi Polysaccharide Antigen for Traveler's Diarrhea - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Traveler's Diarrhea - Recent Pipeline Updates
Traveler's Diarrhea - Discontinued Products
Traveler's Diarrhea - Discontinued Products
Traveler's Diarrhea - Product Development Milestones
Featured News & Press Releases
Oct 04, 2013: Santarus Announces Presentation of Phase III Data for Rifamycin SV MMX in Travelers’ Diarrhea
Sep 11, 2012: Santarus Announces Positive Top-Line Phase III Results for Rifamycin SV MMX in Travelers' Diarrhea
Aug 17, 2011: TD Vaccines to Present ACE527 Phase II Data at Sachs 11th Annual Biotech in Europe
Sep 14, 2009: Data from Optimers Second Phase III Study of Prulifloxacin Presented At Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Sep 02, 2009: Optimer Pharmaceuticals Announces Presentations Of Additional Phase III Prulifloxacin Data At Upcoming ICAAC Annual Meeting
Feb 26, 2009: Optimer Pharmaceuticals Announces Publication In Peer-Reviewed Journal About Prulifloxacins Antibacterial Activity Against Infectious Diarrhea Producing Bacteria
Feb 24, 2009: Optimer Pharmaceuticals Announces Positive Results From Second Phase III Study Of Prulifloxacin For Infectious Diarrhea In Travelers
Oct 20, 2008: Data from Optimer Pharmaceuticals Prulifloxacin Phase III Trial In Travelers Diarrhea Presented At ICAAC/IDSA Annual Meeting
Sep 02, 2008: Optimer Pharmaceuticals Completes Enrollment In Second Prulifloxacin Phase III Clinical Trial
Jul 16, 2008: Optimer Pharmaceuticals Announces Positive Results In Prulifloxacin Phase III Study
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Traveler's Diarrhea, H2 2015
Number of Products under Development for Traveler's Diarrhea - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Late Stage Development, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Investigation by Universities/Institutes, H2 2015
Traveler's Diarrhea - Pipeline by Chiesi Farmaceutici SpA, H2 2015
Traveler's Diarrhea - Pipeline by Cosmo Pharmaceuticals S.p.A, H2 2015
Traveler's Diarrhea - Pipeline by GlaxoSmithKline Plc, H2 2015
Traveler's Diarrhea - Pipeline by Nippon Shinyaku Co., Ltd., H2 2015
Traveler's Diarrhea - Pipeline by Prokarium Limited, H2 2015
Traveler's Diarrhea - Pipeline by Scandinavian Biopharma Holding AB, H2 2015
Traveler's Diarrhea - Pipeline by Sigmoid Pharma Limited, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Traveler's Diarrhea Therapeutics - Recent Pipeline Updates, H2 2015
Traveler's Diarrhea - Discontinued Products, H2 2015
List of Figures
Number of Products under Development for Traveler's Diarrhea, H2 2015
Number of Products under Development for Traveler's Diarrhea - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Targets, H2 2015
Number of Products by Stage and Targets, H2 2015
Number of Products by Mechanism of Actions, H2 2015
Number of Products by Stage and Mechanism of Actions, H2 2015
Number of Products by Routes of Administration, H2 2015
Number of Products by Stage and Routes of Administration, H2 2015
Number of Products by Molecule Types, H2 2015
Number of Products by Stage and Molecule Types, H2 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report